These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 9280323)

  • 21. Pulmonary injury induced by C3a and C5a anaphylatoxins.
    Stimler NP; Hugli TE; Bloor CM
    Am J Pathol; 1980 Aug; 100(2):327-48. PubMed ID: 6967702
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radioimmunoassay for anaphylatoxins: a sensitive method for determining complement activation products in biological fluids.
    Wagner JL; Hugli TE
    Anal Biochem; 1984 Jan; 136(1):75-88. PubMed ID: 6711816
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complement activation during liver transplantation.
    Tomasdottir H; Henriksson BA; Bengtson JP; Bengtsson A; Stenqvist O; Persson H
    Transplantation; 1993 Apr; 55(4):799-802. PubMed ID: 8475554
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of C3a and C5a anaphylatoxins on guinea-pig isolated blood vessels.
    Marceau F; Hugli TE
    J Pharmacol Exp Ther; 1984 Sep; 230(3):749-54. PubMed ID: 6332191
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The ischaemic leg as a source of complement activation.
    Bengtson A; Holmberg P; Heideman M
    Br J Surg; 1987 Aug; 74(8):697-700. PubMed ID: 3498527
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Re-evaluation of the storage conditions for blood samples which are used for determination of complement activation.
    Stöve S; Klos A; Bautsch W; Köhl J
    J Immunol Methods; 1995 May; 182(1):1-5. PubMed ID: 7769237
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Complement activation produced by biomaterials.
    Chenoweth DE
    Artif Organs; 1988 Dec; 12(6):508-10. PubMed ID: 3265053
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In-vitro activation of complement system by lactic acidosis in newborn and adults.
    Hecke F; Hoehn T; Strauss E; Obladen M; Sonntag J
    Mediators Inflamm; 2001 Feb; 10(1):27-31. PubMed ID: 11324901
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Generation of human C3a, C4a, and C5a anaphylatoxins by protein A of Staphylococcus aureus and immobilized protein A reagents used in serotherapy of cancer.
    Langone JJ; Das C; Bennett D; Terman DS
    J Immunol; 1984 Aug; 133(2):1057-63. PubMed ID: 6610702
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anaphylatoxins C3a and C5a adsorption on acrylonitrile membrane of hollow-fiber and plate dialyzer--an in vivo study.
    Kandus A; Ponikvar R; Drinovec J; Kladnik S; Ivanovich P
    Int J Artif Organs; 1990 Mar; 13(3):176-80. PubMed ID: 2347666
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human plasmacytoid dendritic cells express receptors for anaphylatoxins C3a and C5a and are chemoattracted to C3a and C5a.
    Gutzmer R; Köther B; Zwirner J; Dijkstra D; Purwar R; Wittmann M; Werfel T
    J Invest Dermatol; 2006 Nov; 126(11):2422-9. PubMed ID: 16778800
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A recombinant hybrid anaphylatoxin with dual C3a/C5a activity.
    Bautsch W; Kretzschmar T; Stühmer T; Kola A; Emde M; Köhl J; Klos A; Bitter-Suermann D
    Biochem J; 1992 Nov; 288 ( Pt 1)(Pt 1):261-6. PubMed ID: 1445269
    [TBL] [Abstract][Full Text] [Related]  

  • 33. C3a and C5a anaphylatoxins bind to heparin-based sorbent in low density lipoprotein apheresis: in vitro and in vivo investigations.
    Sinitsyn VV; Bokchubaev ET; Mamontova AG; Ovtrakht NV; Nasonov EL; Konovalov GA; Kukharchuk VV
    Artif Organs; 1992 Jun; 16(3):291-3. PubMed ID: 10078261
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interleukin-1 upregulates anaphylatoxin receptors on mononuclear cells.
    Takabayashi T; Shimizu S; Clark BD; Beinborn M; Burke JF; Gelfand JA
    Surgery; 2004 May; 135(5):544-54. PubMed ID: 15118592
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anaphylatoxin levels in human aqueous humor.
    Mondino BJ; Sumner H
    Invest Ophthalmol Vis Sci; 1986 Aug; 27(8):1288-92. PubMed ID: 3488296
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complement factors C3a and C5a are increased in bronchoalveolar lavage fluid after segmental allergen provocation in subjects with asthma.
    Krug N; Tschernig T; Erpenbeck VJ; Hohlfeld JM; Köhl J
    Am J Respir Crit Care Med; 2001 Nov; 164(10 Pt 1):1841-3. PubMed ID: 11734433
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complement activation and anaphylatoxin (C3a and C5a) formation in preeclampsia and by amniotic fluid.
    Haeger M; Bengtson A; Karlsson K; Heideman M
    Obstet Gynecol; 1989 Apr; 73(4):551-6. PubMed ID: 2784554
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of cytokines by human astrocytomas following stimulation by C3a and C5a anaphylatoxins: specific increase in interleukin-6 mRNA expression.
    Sayah S; Ischenko AM; Zhakhov A; Bonnard AS; Fontaine M
    J Neurochem; 1999 Jun; 72(6):2426-36. PubMed ID: 10349852
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complement factor C5a in acute exacerbation of Chronic Obstructive Pulmonary Disease.
    Marc MM; Kristan SS; Rozman A; Kern I; Flezar M; Kosnik M; Korosec P
    Scand J Immunol; 2010 May; 71(5):386-91. PubMed ID: 20500690
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Normal pregnancy is characterized by systemic activation of the complement system.
    Richani K; Soto E; Romero R; Espinoza J; Chaiworapongsa T; Nien JK; Edwin S; Kim YM; Hong JS; Mazor M
    J Matern Fetal Neonatal Med; 2005 Apr; 17(4):239-45. PubMed ID: 16147832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.